BioVergence helps owners of IP, data, milestones, royalties, and development programs structure financeable opportunities for qualified investors and strategic capital partners.
We design asset-specific pathways that broaden access to capital while preserving operational control.
We’re building blockchain technology to support compliant structured digital securities and asset-level financing, expanding access to a larger potential market than private deals can reach. Where legally permitted, these technologies may support transferability and liquidity, alongside clearer terms and non-dilutive financing. Access to these technologies can accelerate research, reduce duplicated efforts, and save costs.
Reveal intrinsic value in IP, data, royalties, and development programs.
Tailored structures that reflect unique risk/return profiles.
Institutional and strategic capital partners aligned to the asset.
Economic exposure can be separated from operational control.
Get the answers you need. Browse our FAQs for more information about BioVergence.
Digital securities turn a right — intellectual property, a royalty stream, a milestone payment, a share of a program — into a digital instrument that can be owned, tracked, and transferred
Scientists, labs, universities, builders, funders, and decentralized communities. Whether you have unused IP, want to contribute to an open R&D venture, or are building tools for scientific collaboration, there’s a place for you here.
Assets are submitted by contributors, labs, and institutions — often underused IP or early-stage research. The BioVergence protocol standardizes and tokenizes these assets so they can be licensed and built upon with full attribution and incentive alignment.
Head to the App or Hive portal to submit a project proposal. You can start with your own IP, remix an existing asset from the Library, or bring a team together to co-create. Projects that meet core standards can receive governance-backed support or funding.
1. Confidential intake: Share a high-level overview under NDA.
2. Evaluate and rank: Diligence, benchmarking, value drivers.
3. Structure and package: Tailored security / financing design.
4. Access capital and reporting: Aligned capital, disclosures, reporting.
Our dedicated team is here to provide personalized support and guidance to ensure you have all the information you need. Contact us today to learn more about our products, services, or anything else you’re curious about.
Email: malhotra@biovergence.xyz